Doctor profile · Federal record

Dr. Anita Tharian, DO

Medical Oncology Physician (CMS: Hematology/Oncology) · Internal Medicine Physician · Hematology & Oncology Physician · Mesquite, TX

  • NPI 1457367112
  • Accepts Medicare
  • MIPS 0.0 / 100 · 2023
  • 24 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
18601 Lbj Fwy Ste 315
Mesquite, TX 751505612
(469) 547-6541
fax (469) 547-6545

Credentials & registration

NPPES · NUCC
NPI registered
August 2006 — 20 yrs on file
Profile last updated
November 14, 2011
Year of graduation
2002 — 24 yrs since
Specialty taxonomy
207RX0202X — NUCC code
State license (1)
Texas #M0588
Medicaid (3)
TX #173978101 · TX #173978103 · TX #173978104

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1457367112. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
37,980
Distinct HCPCS
10
Medicare allowed
$1,177,065
HCPCS Description Services Patients Avg allowed
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) 24,480 20 $0
J0897 Injection, denosumab, 1 mg 5,041 37 $23
J1100 Injection, dexamethasone sodium phosphate, 1 mg 2,652 26 $0
J2405 Injection, ondansetron hydrochloride, per 1 mg 2,201 24 $0
A9595 Piflufolastat f-18, diagnostic, 1 millicurie 845 101 $596
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less 479 28 $29
96413 Administration of chemotherapy into vein, 1 hour or less 276 35 $130
78815 Nuclear medicine study from skull base to mid-thigh with ct scan 203 179 $1,547
77063 Screening 3d breast mammography 167 167 $51
77067 Screening mammography 166 166 $125

In context: peer comparison

Among 3 peers in Mesquite Medical Oncology Physician, average services per provider: 899. This provider delivers 42× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$950
Transactions
32
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Astellas Pharma US INC 5 $101.29
GlaxoSmithKline, LLC. 3 $71.79
PharmaEssentia USA Corporation 2 $68.45
Pfizer INC. 3 $60.31
Abbvie INC. 3 $51.62
AstraZeneca Pharmaceuticals Lp 2 $49.20
Regeneron Healthcare Solutions, INC. 2 $48.72
E.R. Squibb & Sons, L.L.C. 2 $46.49
Novartis Pharmaceuticals Corporation 2 $42.43
Gilead Sciences, INC. 2 $39.81
Dendreon Pharmaceuticals LLC 1 $34.44
Rigel Pharmaceuticals, INC. 2 $34.26
Boehringer Ingelheim Pharmaceuticals, INC. 1 $30.89
Sumitomo Pharma America, INC. 1 $28.07
Merck Sharp & Dohme LLC 1 $27.95

By nature of payment

Food and Beverage
$950

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
972
Patients
318
Total drug cost
$638,627
Drug Type Claims Patients Total cost
Anastrozole Generic 232 73 $8,159
Letrozole Generic 112 38 $3,350
Alendronate Sodium Generic 104 31 $1,187
Tamoxifen Citrate Generic 69 18 $2,581
Levothyroxine Sodium Generic 62 23 $899
Venlafaxine Hcl ER (Venlafaxine Hcl) Brand 59 21 $1,316
Eliquis (Apixaban) Brand 48 0 $36,921
Prochlorperazine Maleate Generic 45 29 $698
Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) Brand 40 15 $1,168
Gabapentin Generic 38 16 $648

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Anita Tharian's medical specialty?
Dr. Anita Tharian practices Medical Oncology Physician in Mesquite, TX.
Where does Dr. Anita Tharian practice?
Dr. Anita Tharian practices at 18601 Lbj Fwy Ste 315, Mesquite, TX 751505612. Office phone: 4695476541.
What is Dr. Anita Tharian's NPI?
Dr. Anita Tharian's National Provider Identifier (NPI) is 1457367112, issued by NPPES.
Does Dr. Anita Tharian accept Medicare assignment?
Yes. Dr. Anita Tharian accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Anita Tharian commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138); Injection, denosumab, 1 mg (HCPCS J0897); Injection, dexamethasone sodium phosphate, 1 mg (HCPCS J1100). Source: CMS Medicare Physician & Other Practitioners file.